Efficacy, Safety and Tolerability of Givinostat in Non-ambulant Patients With Duchenne Muscular Dystrophy
Clinical trial NCT05933057 · RECRUITING
Trial details
- NCT number
- NCT05933057
- Sponsor
- Italfarmaco
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-19
- Primary completion
- 2028-02-01
- Enrollment
- 138
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.